Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Akeso Biopharma Inc (9926 HK)
Watchlist
186
Analysis
Health Care
•
China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Akeso Biopharma Inc
•
20 Mar 2023 08:55
Akeso Biopharma (9926.HK) - Behind the Outstanding Performance in 2022 and the Potential Challenges
Akeso's strong sales were driven by off-label use, and sales growth could significantly slow down over time. Due to high R&D expense, it's hard to...
Xinyao (Criss) Wang
Follow
317 Views
Share
bullish
•
Akeso Biopharma Inc
•
17 Mar 2023 09:02
[Akeso Inc. (9926 HK) Target Price Change]: A Mini-BeiGene in the Making…Reiterate BUY
Given Summit’s US$500mn upfront and up to US$5bn upfront payment for Ivonescimab (PD-1/VEGF) (AK112), we now forecast Akeso to achieve non-IFRS...
Blue Lotus Research Institute
Follow
446 Views
Share
bearish
•
Thematic (Sector/Industry)
•
12 Mar 2023 09:20
China Healthcare Weekly (Mar.10)- Three Conditions to Be Biopharma, Anticipate the Collapse, DS-8201
Becoming big pharma needs to meet three conditions. If investors can understand the logic of marketing, they may anticipate potential collapse. ADC...
Xinyao (Criss) Wang
Follow
383 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 Mar 2023 10:13
China TMT Update(Mar.10): 9926hk/XPEV/981.HK/1347.HK/ACMR: Xpeng to Unveils Facelift of P7 (+)
Akeso and China's 2nd largest pharmaceutical distributor signed collaborative R&D agreement ; Xpeng to officially unveils facelift of P7:...
Blue Lotus Research Institute
Follow
427 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Mar 2023 09:50
China TMT Update(Mar.8): 9926HK,ZLAB,3690HK: Meituan Closure of Self-Operated Taxi Business (+)
ZLAB:HBM announced Phase III success of FcRn drug treating MG(-) 3690HK:Meituan closure of self-operated taxi business may have 6% benefit to net...
Blue Lotus Research Institute
Follow
286 Views
Share
First
Previous
10
11
12
13
14
15
16
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x